Jamie L. Reynoso, the Chief Executive Officer of Clover Health Investments, has sold 4,066 shares of the company’s Class A Common Stock. This transaction occurred on October 19, 2026, at an average price of $4.41 per share. The sale is part of a Rule 10b5-1 trading plan that Reynoso adopted on March 12, 2026. This move is significant as it highlights ongoing trading activity within the healthcare industry, particularly among Medicare Advantage plans.
Clover Health Investments, Inc. is a company focused on providing health insurance services, specifically in the Medicare Advantage sector. The company is incorporated in Delaware and operates under the Central Index Key (CIK) of 0001801170. Clover Health has been active in the market, with recent filings indicating a variety of transactions, including multiple Form 4 and Form 144 submissions.
According to the latest SEC filing (accession number 0001839066-26-000057), the sale of shares by Reynoso is documented as a non-derivative transaction, indicating that he disposed of the shares directly. Following this transaction, Reynoso retains ownership of 2,770,351 shares in Clover Health Investments.
This transaction may affect various stakeholders, including investors and analysts who track executive movements and trading patterns within the healthcare sector. Such sales can provide insights into executive confidence in the company and its future prospects.
The filing does not specify what actions may follow this transaction, leaving stakeholders to speculate on potential future developments.